Two Democratic lawmakers are pressing the Treasury Department and IRS to issue formal, actionable guidance on federal income tax treatment for state-legal cannabis businesses - a direct consequence of cannabis products being moved from Schedule I to Schedule III under the Controlled Substances Act. The letter, led by Congressman Steven Horsford of Nevada and Congressman Steve Cohen of Tennessee, targets a tax question that has hung over licensed operators for years: what does rescheduling actually mean for their tax bills?
Why 280E Has Been Such a Heavy Burden
Section 280E of the Internal Revenue Code is the financial pressure point most licensed cannabis operators know by heart. The provision prohibits businesses from deducting ordinary and necessary business expenses if those businesses are "trafficking" in a substance listed on Schedule I or II of the Controlled Substances Act. In practice, that meant a licensed dispensary couldn't deduct rent, payroll, marketing costs, or most operational overhead against federal taxable income - expenses that any comparable retail business would treat as standard deductions.
The result was a tax structure that effectively penalized compliance. Operators running fully licensed, state-regulated dispensaries paid federal taxes on gross profit rather than net income. For high-volume retailers and vertically integrated multi-state operators, that distinction could represent a significant portion of annual revenue absorbed by federal tax liability - money that couldn't be reinvested in inventory, staffing, or store infrastructure.
Here's the thing: Schedule III placement changes that calculus. As the lawmakers note in their letter, because qualifying cannabis products now sit outside Schedule I and II, Section 280E no longer applies to qualifying state-legal cannabis-related businesses. That's not a minor procedural update. It's a material shift in the federal tax framework governing every licensed operator in the country.
The Guidance Gap - And Why It Creates Real Risk
The rescheduling creates opportunity, but the absence of formal IRS guidance creates exposure. Without clear agency direction, individual operators, their accountants, and their legal counsel are left interpreting the change on their own - and inconsistent interpretation is exactly how tax disputes start.
The lawmakers cite the National Taxpayer Advocate directly: "the IRS must issue guidance and provide education in a proactive and timely manner." That framing matters. Proactive guidance isn't just helpful - it's the difference between an industry that adapts efficiently and one that spends years in administrative disputes over deduction eligibility, amended returns, and audit exposure. For a single-location dispensary working with a small accounting firm, that uncertainty has real operational cost.
The letter specifically flags two areas requiring clarity: treatment of ordinary and necessary business deductions, and access to tax credits. Both are consequential. Deduction eligibility affects every operator's taxable income calculation starting from the point rescheduling takes effect. Tax credits - including potential small-business credits - could benefit operators who have been categorically excluded from those provisions. The timeline question matters too. When does 280E relief apply? Does it affect the current tax year? Amended prior returns? These aren't hypotheticals; they're questions licensed operators and their CPAs are already asking.
What Operators and Their Advisors Should Watch For
The letter asks Treasury and the IRS to coordinate with the Small Business Administration to ensure guidance reaches businesses that may not have sophisticated federal tax infrastructure in place. That's a notable ask - and a realistic one. A significant portion of state-licensed cannabis retailers are small businesses, often operating single locations in markets where regulatory compliance already consumes substantial management attention. Getting actionable guidance through SBA channels, not just federal register notices, reflects the practical reality of who is most affected.
For multi-state operators and larger vertically integrated companies, the stakes are different but no less urgent. These businesses have tax teams capable of parsing IRS guidance the day it drops - but they also have the most to gain or lose depending on how deductions are structured retrospectively. Their advisors will want clarity on whether amended returns are viable and what documentation standards the IRS will expect for deductions that were previously disallowed.
Treasury has indicated that guidance is forthcoming. The lawmakers are pushing for that guidance to arrive swiftly and with enough specificity to be operationally useful - not a general statement of principles, but clear rules operators and their accountants can act on. The difference matters. Vague guidance produces inconsistent compliance; inconsistent compliance produces audits.
The Broader Compliance Implication
Cannabis retailers already operate inside a layered compliance environment - state licensing requirements, seed-to-sale tracking systems, METRC reporting, compliant packaging mandates, point-of-sale documentation, and excise tax obligations that vary by jurisdiction. Federal tax treatment has been one more variable that licensed operators couldn't fully control. A clean, timely IRS ruling on 280E applicability post-rescheduling would remove at least one significant source of uncertainty from that stack.
What's striking about the Horsford-Cohen letter is that it frames this not as a cannabis-specific accommodation, but as basic tax administration - the kind of proactive guidance the IRS owes any sector facing a material change in applicable law. That argument is hard to dismiss. Whatever one's position on cannabis policy, the tax administration principle holds: businesses that are now legally operating under a different regulatory classification deserve to know what the rules are.
The letter is a signal, not a resolution. But it adds congressional pressure to a question that licensed operators, their investors, and their advisors have needed answered since the rescheduling took effect.
